COMPARISON OF THE RITUXIMAB(RTM) EFFICACY IN MONOTHERAPY REGIMEN AND IN COMBINATION WITH IMMUNOSUPPRESSANTS IN SYSTEMIC SCLEROSIS (SSC) WITH INTERSTITIAL LUNG DISEASE (ILD)
Session Name
AS24 - Pulmonary Manifestations of Systemic Disease
Presentation Type
Abstract Submission